Mitochondrial medicine and the neurodegenerative mitochondriopathies

N/ACitations
Citations of this article
35Readers
Mendeley users who have this article in their library.

Abstract

Neurodegenerative diseases are a common late-life scourge for which diseasemodifying treatments are sorely needed. Mitochondrial perturbation is commonly observed in these diseases, so pursuing treatment development strategies that target mitochondria or processes affected by mitochondria seems reasonable. This review discusses the rationale underlying past and current efforts to treat neurodegenerative diseases using mitochondrial medicine, and tries to predict how future efforts might proceed. © 2009 by the authors;.

Cite

CITATION STYLE

APA

Swerdlow, R. H. (2009). Mitochondrial medicine and the neurodegenerative mitochondriopathies. Pharmaceuticals, 2(3), 150–167. https://doi.org/10.3390/ph2030150

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free